Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Plasma and Hemodynamic Markers During Hepatectomy

Completed

Conditions: Hepatorenal Syndrome, Liver Regeneration

Interventions: Procedure: Liver resection

First Posted Date: 2012-10-04

Last Posted Date: 2015-04-07

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 100

Registration Number: NCT01700231

Locations: 🇦🇹
General Hospital Vienna, Vienna, Austria

ABO Blood Group Antibody Elimination by a Combination of Semiselective Immunoadsorption Therapy and Membrane Filtration

Not Applicable

Completed

Conditions: Immunology

Interventions: Device: Semiselective IA
Device: Membrane filtration

First Posted Date: 2012-10-03

Last Posted Date: 2018-01-17

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 14

Registration Number: NCT01698736

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.

Not Applicable

Completed

Conditions: Non-alcoholic Fatty Liver Disease
Non-alcoholic Steatohepatitis

Interventions: Dietary Supplement: High oral Fructose challenge (150g per day for 28 days)

First Posted Date: 2012-10-01

Last Posted Date: 2015-09-28

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 10

Registration Number: NCT01696487

Locations: 🇦🇹
Medical University of Vienna, General Hospital of Vienna, Vienna, Austria

Effect of Shock Waves on Tooth Movement and Miniscrew Stability

Phase 2

Completed

Conditions: Mesial Movement of Teeth
Miniscrew Stability

Interventions: Device: Extracorporeal shockwave therapy
Device: ESWT placebo

First Posted Date: 2012-09-28

Last Posted Date: 2015-10-12

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 30

Registration Number: NCT01695928

Locations: 🇦🇹
Bernhard Gottlieb University clinic of Dentistry, Vienna, Austria

The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers

Phase 4

Completed

Conditions: Healthy Human Male Subjects

Interventions: Drug: Liraglutide
Drug: Placebo

First Posted Date: 2012-09-27

Last Posted Date: 2012-09-27

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 16

Registration Number: NCT01695109

Locations: 🇦🇹
Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria

Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation

Phase 4

Completed

Conditions: Retinal Oxygenation
Retinal Blood Flow

Interventions: Drug: 100% oxygen breathing
Drug: 15% oxygen in N2 breathing
Drug: 12% oxygen in N2 breathing

First Posted Date: 2012-09-25

Last Posted Date: 2013-01-30

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 30

Registration Number: NCT01692821

Locations: 🇦🇹
Medical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria

Molecular Adsorbent Recirculating System (MARS®) in Hypoxic Hepatitis

Phase 2

Conditions: Shock Liver
Hypoxic Hepatitis
Hypoxic Liver Injury
Acute Liver Failure
Ischemic Hepatitis

Interventions: Device: MARS

First Posted Date: 2012-09-24

Last Posted Date: 2016-09-22

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 40

Registration Number: NCT01690845

Locations: 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
🇦🇹
Medical University Vienna, Dpt. of Internal Medicine 3, Div. of Gastroenterology and Hepatology, Vienna, Austria

Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology

Completed

Conditions: Pulmonary Fibrosis

First Posted Date: 2012-09-19

Last Posted Date: 2016-03-16

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 80

Registration Number: NCT01687946

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Influence of Skeletal Muscle Paralysis on Metabolism in Hypothermic Patients After Cardiac Arrest

Not Applicable

Completed

Conditions: Critical Illness
Cardiac Arrest

Interventions: Drug: Placebo
Drug: Rocuronium

First Posted Date: 2012-09-11

Last Posted Date: 2017-08-29

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 43

Registration Number: NCT01683006

Locations: 🇦🇹
Medical University Vienna, Vienna, Austria

Corneal Cross Linking and Topography Guided Excimer Laser Treatment

Phase 3

Terminated

Conditions: Keratoconus
Pellucid Marginal Degeneration

Interventions: Other: Corneal Cross Linking
Other: Topography guided Excimer Laser treatment and Corneal Cross Linking

First Posted Date: 2012-09-11

Last Posted Date: 2017-04-26

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 30

Registration Number: NCT01682993

Locations: 🇦🇹
Medical University of Vienna, Department of Ophthalmology, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy